These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 19274665)
1. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665 [TBL] [Abstract][Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells. Xie Y; Wolff DW; Lin MF; Tu Y Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995 [TBL] [Abstract][Full Text] [Related]
4. Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness. Minamiguchi K; Kawada M; Someno T; Ishizuka M Biochem Biophys Res Commun; 2003 Jul; 306(3):629-36. PubMed ID: 12810065 [TBL] [Abstract][Full Text] [Related]
9. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells. Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372 [TBL] [Abstract][Full Text] [Related]
10. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
12. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517 [TBL] [Abstract][Full Text] [Related]
13. Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. Tanner MJ; Welliver RC; Chen M; Shtutman M; Godoy A; Smith G; Mian BM; Buttyan R PLoS One; 2011 Jan; 6(1):e16027. PubMed ID: 21267466 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase pathway is involved in androgen-independent PSA gene expression in LNCaP cells. Franco OE; Onishi T; Yamakawa K; Arima K; Yanagawa M; Sugimura Y; Kawamura J Prostate; 2003 Sep; 56(4):319-25. PubMed ID: 12858361 [TBL] [Abstract][Full Text] [Related]
16. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Kasina S; Macoska JA Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379 [TBL] [Abstract][Full Text] [Related]
17. Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Yu S; Yeh CR; Niu Y; Chang HC; Tsai YC; Moses HL; Shyr CR; Chang C; Yeh S Prostate; 2012 Mar; 72(4):437-49. PubMed ID: 21739465 [TBL] [Abstract][Full Text] [Related]
18. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Gleave M; Hsieh JT; Gao CA; von Eschenbach AC; Chung LW Cancer Res; 1991 Jul; 51(14):3753-61. PubMed ID: 1712249 [TBL] [Abstract][Full Text] [Related]
19. Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Kawamura S; Sato I; Wada T; Yamaguchi K; Li Y; Li D; Zhao X; Ueno S; Aoki H; Tochigi T; Kuwahara M; Kitamura T; Takahashi K; Moriya S; Miyagi T Cell Death Differ; 2012 Jan; 19(1):170-9. PubMed ID: 21681193 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]